All > Recurrent Glioblastoma > Glioma

Procedure: LITT for Glioblastoma

Central Maryland Radiation Oncology, Columbia, MD
Glioblastoma+3 More ConditionsProcedure: LITT - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new way to treat patients with brain tumors that have come back. The treatment involves using a laser to heat up and destroy the tumor, and then using radiation to kill any remaining cancer cells.

Eligible Conditions
  • Glioblastoma
  • Tumors
  • Brain Tumor

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
C134
1
temozolomide
1
Cohort 1

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 2 years

2 Years
Median progression-free survival
Progression-free survival at 6 months
2 years
1-year overall survival
Adverse Events
Median overall survival
Overall response rate
Quality of Life before, during, and after treatment

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
C134
1
temozolomide
1
Cohort 1

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Experimental: LITT with Hypofractionated radiation therapy
1 of 1

Experimental Treatment

32 Total Participants · 1 Treatment Group

Primary Treatment: Procedure: LITT · No Placebo Group · N/A

Experimental: LITT with Hypofractionated radiation therapyExperimental Group · 2 Interventions: Procedure: LITT, Hypo-Fractionated Radiation Therapy · Intervention Types: Device, Radiation

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
633 Previous Clinical Trials
357,353 Total Patients Enrolled
3 Trials studying Glioblastoma
63 Patients Enrolled for Glioblastoma
Keep Punching FoundationUNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
1 Trials studying Glioblastoma
32 Patients Enrolled for Glioblastoma

Eligibility Criteria

Age 18+ · All Participants · 12 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the current participant count for this investigation?

"Affirmative, the information present on clinicaltrials.gov reveals that this medical experiment is actively searching for subjects. It was initially posted online on August 1st 2020 and updated lastly on October 10th 2022. 32 individuals are necessary from 4 different research sites." - Anonymous Online Contributor

Unverified Answer

To what extent is this trial being conducted in hospitals across the country?

"This trial is currently being conducted at 4 separate facilities located in Bel Air, Glen Burnie, Columbia and a few other locations. To reduce commute times for participants, it may be best to select the clinic that is geographically closest." - Anonymous Online Contributor

Unverified Answer

Are participants still being recruited for this trial?

"Affirmative, the information hosted on clinicaltrials.gov indicate that this medical experiment is actively searching for volunteers. It was first posted in January 8th 2020 and has since been modified with its most recent update happening October 10th 2022. This research requires 32 participants from 4 distinct sites to be enrolled." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top